Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1999 Sep-Oct;5(5):694–700. doi: 10.3201/eid0505.990511

Diphtheria antitoxin levels in the Netherlands: a population-based study.

H E de Melker 1, G A Berbers 1, N J Nagelkerke 1, M A Conyn-van Spaendonck 1
PMCID: PMC2627715  PMID: 10511526

Abstract

In a population-based study in the Netherlands, diphtheria antitoxin antibodies were measured with a toxin-binding inhibition assay in 9, 134 sera from the general population and religious communities refusing vaccination. The Dutch immunization program appears to induce long-term protection against diphtheria. However, a substantial number of adults born before the program was introduced had no protective diphtheria antibody levels. Although herd immunity seems adequate, long-term population protection cannot be assured. As more than 60% of orthodox reformed persons have antibody levels lower than 0.01 IU/ml, introduction of diphtheria into religious communities refusing vaccination may constitute a danger of spread of the bacterium.

Full Text

The Full Text of this article is available as a PDF (124.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böttiger M., Pettersson G. Vaccine immunity to diphtheria: a 20-year follow-up study. Scand J Infect Dis. 1992;24(6):753–758. doi: 10.3109/00365549209062460. [DOI] [PubMed] [Google Scholar]
  2. Hardy I. R., Dittmann S., Sutter R. W. Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet. 1996 Jun 22;347(9017):1739–1744. doi: 10.1016/s0140-6736(96)90811-9. [DOI] [PubMed] [Google Scholar]
  3. Hendriksen C. F., van der Gun J. W., Kreeftenberg J. G. Combined estimation of tetanus and diphtheria antitoxin in human sera by the in vitro Toxin-Binding Inhibition (ToBI) test. J Biol Stand. 1989 Apr;17(2):191–200. doi: 10.1016/0092-1157(89)90009-7. [DOI] [PubMed] [Google Scholar]
  4. Jenum P. A., Skogen V., Danilova E., Eskild A., Sjursen H. Immunity to diphtheria in northern Norway and northwestern Russia. Eur J Clin Microbiol Infect Dis. 1995 Sep;14(9):794–798. doi: 10.1007/BF01690995. [DOI] [PubMed] [Google Scholar]
  5. Kjeldsen K., Simonsen O., Heron I. Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet. 1985 Apr 20;1(8434):900–902. doi: 10.1016/s0140-6736(85)91675-7. [DOI] [PubMed] [Google Scholar]
  6. Kjeldsen K., Simonsen O., Heron I. Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis. 1988;20(2):177–185. doi: 10.3109/00365548809032435. [DOI] [PubMed] [Google Scholar]
  7. Maple P. A., Efstratiou A., George R. C., Andrews N. J., Sesardic D. Diphtheria immunity in UK blood donors. Lancet. 1995 Apr 15;345(8955):963–965. doi: 10.1016/s0140-6736(95)90705-x. [DOI] [PubMed] [Google Scholar]
  8. Oostvogel P. M., van Wijngaarden J. K., van der Avoort H. G., Mulders M. N., Conyn-van Spaendonck M. A., Rümke H. C., van Steenis G., van Loon A. M. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet. 1994 Sep 3;344(8923):665–670. doi: 10.1016/s0140-6736(94)92091-5. [DOI] [PubMed] [Google Scholar]
  9. Schneerson R., Robbins J. B., Taranger J., Lagergård T., Trollfors B. A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned. Lancet. 1996 Nov 9;348(9037):1289–1292. doi: 10.1016/S0140-6736(96)05243-9. [DOI] [PubMed] [Google Scholar]
  10. Stark K., Barg J., Molz B., Vormwald A., Bienzle U. Immunity against diphtheria in blood donors in East Berlin and West Berlin. Lancet. 1997 Sep 27;350(9082):932–932. doi: 10.1016/S0140-6736(05)63268-0. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES